Lv11
16 积分 2021-07-28 加入
CRISPR activation and interference screens decode stimulation responses in primary human T cells
1小时前
待确认
Structural mechanism for NEK7-licensed activation of NLRP3 inflammasome
6小时前
已完结
Discovery of KT-413, a Targeted Protein Degrader of IRAK4 and IMiD Substrates Targeting MYD88 Mutant Diffuse Large B-Cell Lymphoma
6天前
已完结
Interleukin-1 Receptor-Associated Kinase 4 (IRAK4) Degraders for Treating Inflammatory Diseases: Advances and Prospects
7天前
已完结
Discovery of a Novel Orally Bioavailable FLT3-PROTAC Degrader for Efficient Treatment of Acute Myeloid Leukemia and Overcoming Resistance of FLT3 Inhibitors
15天前
已完结
BTK inhibitors: past, present, and future
15天前
已完结
The emerging safety profile of JAK inhibitors in rheumatic disease
21天前
已完结
Drugging the NLRP3 inflammasome: from signalling mechanisms to therapeutic targets
22天前
已完结
PROTACs reach clinical development in inflammatory skin disease
1个月前
已完结
ERK signalling: a master regulator of cell behaviour, life and fate
2个月前
已完结
皖公网安备34019202002308
